Yulian Konechnyi is an Associate Professor at the Department
of Microbiology, Faculty of Medicine No. 2, Danylo Halytsky Lviv National
Medical University, Ukraine, and a practicing primary care physician
specializing in internal medicine at the Outpatient Clinic of Family Medicine “Vulyk”.
He holds a PhD in medicine, with his dissertation focusing on the species
spectrum and biological properties of bacterial and fungal pathogens in
healthcare-associated infections, as well as the antimicrobial activity of
4-thiazolidinone derivatives. His research interests encompass clinical
microbiology, antimicrobial resistance, and drug discovery, particularly the
search for novel antimicrobial and antifungal agents. As a member of several
professional organizations, including the European Society of Clinical
Microbiology and Infectious Diseases (ESCMID) and the American Society for
Microbiology (ASM), he actively participates in the global efforts to combat
antimicrobial resistance. He also contributes as a reviewer for high-impact
journals such as Antibiotics. He is committed to advancing medical education,
research, and patient care through interdisciplinary collaboration and a focus
on evidence-based approaches.
Yulian Konechnyi is an Associate Professor at the Department
of Microbiology, Faculty of Medicine No. 2, Danylo Halytsky Lviv National
Medical University, Ukraine, and a practicing primary care physician
specializing in internal medicine at the Outpatient Clinic of Family Medicine “Vulyk”.
He holds a PhD in medicine, with his dissertation focusing on the species
spectrum and biological properties of bacterial and fungal pathogens in
healthcare-associated infections, as well as the antimicrobial activity of
4-thiazolidinone derivatives. His research interests encompass clinical
microbiology, antimicrobial resistance, and drug discovery, particularly the
search for novel antimicrobial and antifungal agents. As a member of several
professional organizations, including the European Society of Clinical
Microbiology and Infectious Diseases (ESCMID) and the American Society for
Microbiology (ASM), he actively participates in the global efforts to combat
antimicrobial resistance. He also contributes as a reviewer for high-impact
journals such as Antibiotics. He is committed to advancing medical education,
research, and patient care through interdisciplinary collaboration and a focus
on evidence-based approaches.